Optimal’s automation system integration and software capabilities will be offered alongside Bruker’s analytical instruments, life-science and diagnostic products
The Optimal Group, consisting of Optimal Industrial Automation and Optimal Industrial Technologies, has been acquired by Bruker Corporation. The acquisition will enhance Optimal’s vendor-agnostic offering of integrated automated manufacturing process and quality control products for the pharmaceutical and other process industries.
Optimal’s offering is aligned with smart manufacturing trends, including data-driven, flexible processes designed to support optimised processes, consistent product quality and sustainability.
synTQ, the company’s PAT Knowledge Management platform, already supports many pharmaceutical manufacturers, and the company supports various companies in the chemical, fast-moving consumer goods as well as food & beverage markets.
Combined with Bruker’s range of analytical instruments, life-science and diagnostic products, Optimal’s automation system integration and software capabilities are hoped to help customers benefit from more comprehensive solutions, especially but not limited for small molecule, biologics and new drug modalities companies.
A clear commitment to vendor neutrality is retained by Optimal and its products, the company says. synTQ connects an increasing number of instrumentation, MVA packages, automation systems or other third-party systems (such as MES, historian, LIMS) from any vendor. This approach allows customers to take advantage of technologies embedded into flexible systems that suit the customer’s needs and allows them to expand their existing infrastructure as it evolves.
Dr Falko Busse, President of the Bruker BioSpin Group, said: “The acquisition of Optimal is a very exciting step for Bruker as it supports more comprehensive solutions for the biopharmaceutical industry, now adding the capabilities to integrate cutting-edge systems into biopharma manufacturing processes and workflows. We welcome the Optimal team with their strong PAT and automation expertise and, together, are eager to support biotech and pharmaceutical companies in increasing their manufacturing efficiency and flexibility – a global need highlighted by the response to the pandemic crisis.”
Martin Gadsby, co-founder of the Optimal group, said: “We are delighted to become part of the Bruker family. Optimal and Bruker together are a perfect fit – we share the common ethos of innovation with integrity, together with our industry recognition as a high-quality solutions provider delivering tangible benefits to our customers.
“I am proud of what this company has accomplished for all stakeholders through these past 35 years. The entire staff at Optimal is very excited about becoming part of the Bruker team and the opportunities that a large provider of analytical instruments offers while being able to remain a vendor-agnostic solution provider.”